Sphera Funds Management’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,420
| Closed | -$61.5K | – | 112 |
|
|
2025
Q1 | $61.5K | Sell |
48,420
-77,908
| -62% | -$98.9K | 0.01% | 110 |
|
|
2024
Q4 | $120K | Sell |
126,328
-20,129
| -14% | -$19.1K | 0.02% | 101 |
|
|
2024
Q3 | $243K | Sell |
146,457
-221,125
| -60% | -$367K | 0.04% | 105 |
|
|
2024
Q2 | $662K | Hold |
367,582
| – | – | 0.09% | 103 |
|
|
2024
Q1 | $1.22M | Buy |
+367,582
| New | +$1.22M | 0.17% | 85 |
|
|
2022
Q1 | – | Sell |
-137,857
| Closed | -$758K | – | 78 |
|
|
2021
Q4 | $758K | Sell |
137,857
-77,502
| -36% | -$426K | 0.08% | 83 |
|
|
2021
Q3 | $1.28M | Hold |
215,359
| – | – | 0.11% | 92 |
|
|
2021
Q2 | $2.34M | Buy |
215,359
+1,465
| +0.7% | +$15.9K | 0.16% | 91 |
|
|
2021
Q1 | $3.25M | Buy |
+213,894
| New | +$3.25M | 0.25% | 81 |
|